Covaxin Covid-19 vaccine reports higher efficacy in paediatric population

Covaxin is one of the first Covid-19 vaccines in the world to generate data in 2–18-year age group. Data from over 50 million doses given to children in India revealed that side effects were minimal.

from Lifestyle News:Entertainment News,Bollywood Latest News,Box Office Collection Report,Movie Reviews
Read The Rest:financialexpress...